Ding and colleagues identified direct links between IL‐17A, various serum metabolites, and the development of lung cancer, highlighting the significant impact of inflammatory and metabolic imbalances on the pathogenesis of cancer [27]. This evidence concerns the gene IL17A and lung carcinoma.